KaplanSLBarsonWJLinPL. Serotype 19A is the most common serotype causing invasive pneumococcal infections in children. Pediatrics. 2010;125:429-436.
2.
AntachopoulosCTsoliaMNTzanakakiG. Parapneumonic pleural effusions caused by Streptococcus pneumoniae serotype 3 in children immunized with 13-valent conjugated pneumococcal vaccine. Pediatr Infect Dis J. 2014;33:81-83.
3.
MadhiFGodotCBidetPBahuaudMEpaudRCohenR. Serotype 3 pneumococcal pleural empyema in an immunocompetent child after 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2014;33:545-546.
4.
OrangeJSBallowMStiehmER. Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2012;130(3 suppl):S1-S24.
5.
HidalgoHMooreCLeivaLESorensenRU. Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infections. Ann Allergy Asthma Immunol. 1996;76:341-346.
6.
KieningerDMKueperKSteulK. Safety, tolerability, and immunologic noninferiority of a 13-valent pneumococcal conjugate vaccine compared to a 7-valent pneumococcal conjugate vaccine given with routine pediatric vaccinations in Germany. Vaccine. 2010;28:4192-4203.
7.
WeinbergGASzilagyiPG. Vaccine epidemiology: efficacy, effectiveness, and the translational research roadmap. J Infect Dis. 2010;201:1607-1610.
8.
MillerEAndrewsNJWaightPASlackMPGeorgeRC. Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine. Vaccine. 2011;29:9127-9131.
9.
HoPLChanMYChowKHChiuSS. Streptococcus pneumoniae serotype 19A bacteremia in a child fully immunized with 10-valent pneumococcal conjugate vaccine. J Microbiol Immunol Infect. 2014;47:164-165.
10.
LuCYTingYTHuangLM. Severe Streptococcus pneumoniae 19A pneumonia with empyema in children vaccinated with pneumococcal conjugate vaccines [published online March24, 2014]. J Formos Med Assoc. doi:10.1016/j.jfma.2014.02.007.
